FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

704191007: Nivolumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3011226014 Nivolumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3012383017 Nivolumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
55111000195115 nivolumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
828431000172117 nivolumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69661000195117 Nivolumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nivolumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Nivolumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Nivolumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Programmed cell death protein 1 inhibitor (disposition) true Inferred relationship Some
Nivolumab (substance) Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Some
Nivolumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing nivolumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nivolumab (substance) Inferred relationship Some 1
Product containing nivolumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nivolumab (substance) Inferred relationship Some 1
Product containing only nivolumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nivolumab (substance) Inferred relationship Some 1
Nivolumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nivolumab (substance) Inferred relationship Some 1
Nivolumab 10 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nivolumab (substance) Inferred relationship Some 1
Nivolumab 10 mg/mL solution for infusion This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nivolumab (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start